{"mainPropery":{"diseaseId":8417,"diseaseName":"Renal cell carcinoma 4","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8417/renal-cell-carcinoma-4","synonyms":["RCC4"],"synonyms-with-source":[{"name":"RCC4"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/renal-cell-carcinoma' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2162,"resourceId":3371,"resourceName":"The Assistance Fund","descriptionText":"<a href='https://tafcares.org/patients/covered-diseases/' target='_blank'>The Assistance Fund</a> provides various services, including education and financial aid, to help patients with a chronic or serious illness cover the cost of FDA-approved medications. Patients must be U.S citizens or permanent residents.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":51,"genericName":"Sorafenib","tradeName":"Nexavar","tradeLink":"http://www.nexavar-us.com/","manufacturer":"","sponsor":"Bayer Pharmaceutical Corporation","indication":"Treatment of patients with advanced renal cell carcinoma.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/475207-59-1","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a607051.html"},{"productId":101,"genericName":"Aldesleukin","tradeName":"Proleukin®","tradeLink":"https://www.proleukin.com/","manufacturer":"","sponsor":"Chiron Corporation","indication":"Treatment of adults (>18 years old) with metastatic renal cell carcinoma.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/Proleukin","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a692009.html"},{"productId":482,"genericName":"Temsirolimus","tradeName":"Torisel®","tradeLink":"http://torisel.com/","manufacturer":"","sponsor":"Wyeth Pharmaceuticals, Inc.","indication":"Treatment of advanced renal cell carcinoma","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Torisel","medlinePlusLink":"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607071.html"}],"EncodedName":"Renal_cell_carcinoma_4"}